Literature DB >> 2555182

Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene.

E Andrejauskas1, C Moroni.   

Abstract

Immortalized, interleukin-3 (IL-3)-dependent mouse mast cells (PB-3c) were transfected with a human activated c-H-ras gene under the transcriptional control of the mouse mammary tumor virus long terminal repeat. Addition of increasing amounts of dexamethasone resulted in a concentration-dependent increase in expression of the H-ras oncogene. The elevation of p21 ras protein concentrations was paralleled by progressive growth of the transfectants in the absence of exogenous IL-3, leading to complete abrogation of growth-factor requirement at high p21ras levels. The maintenance of the IL-3-independent state required the continuous expression of the H-ras oncogene, since dexamethasone removal was followed by rapid cell death. Expression of the H-ras oncogene induced PB-3c cells to produce IL-3 and granulocyte-macrophage colony-stimulating factor, suggesting that their IL-3-independent proliferation may be due to an autocrine mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555182      PMCID: PMC401260          DOI: 10.1002/j.1460-2075.1989.tb08396.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

2.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  Increased secretion of type beta transforming growth factor accompanies viral transformation of cells.

Authors:  M A Anzano; A B Roberts; J E De Larco; L M Wakefield; R K Assoian; N S Roche; J M Smith; J E Lazarus; M B Sporn
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

4.  Growth-factor-independent proliferation in vitro and tumorigenicity in vivo are associated in basophil/mast-cell lines and their somatic hybrids.

Authors:  J F Conscience; F Fischer
Journal:  Differentiation       Date:  1985       Impact factor: 3.880

5.  Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.

Authors:  J H Pierce; P P Di Fiore; S A Aaronson; M Potter; J Pumphrey; A Scott; J N Ihle
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

6.  Characterization of the cell surface receptor for a multi-lineage colony-stimulating factor (CSF-2 alpha).

Authors:  L S Park; D Friend; S Gillis; D L Urdal
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

7.  Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3.

Authors:  A Rein; J Keller; A M Schultz; K L Holmes; R Medicus; J N Ihle
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

8.  Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes.

Authors:  U R Rapp; J L Cleveland; K Brightman; A Scott; J N Ihle
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

9.  The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.

Authors:  R Jaggi; B Salmons; D Muellener; B Groner
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression.

Authors:  I A McKay; C J Marshall; C Calés; A Hall
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  8 in total

1.  Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions.

Authors:  A Wodnar-Filipowicz; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.

Authors:  M T Mitjavila; J P Le Couedic; N Casadevall; S Navarro; J L Villeval; A Dubart; W Vainchenker
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  Regulation of the salvage pathway of deoxynucleotides synthesis in apoptosis induced by growth factor deprivation.

Authors:  F J Oliver; M K Collins; A López-Rivas
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

5.  Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4.

Authors:  T Satoh; M Nakafuku; A Miyajima; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.

Authors:  C Laker; G Gräning; A Kelso; C Stocking; W Ostertag
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

7.  Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells.

Authors:  R L Darley; T G Hoy; P Baines; R A Padua; A K Burnett
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability.

Authors:  M J Arends; A H McGregor; N J Toft; E J Brown; A H Wyllie
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.